Multifunctional RuO <sub>2</sub> Sensitized Co <sub>3</sub> O <sub>4</sub> Core‐Shell Sonozyme Heterojunctions for Sonodynamic and Nanocatalytic Co‐Amplified Immunotherapy
It is believed that reactive oxygen species (ROS)-mediated immunogenic cell death (ICD) can promote DC maturation and initiate cytotoxic T lymphocytes infiltration, but the limited ROS generation and immunosuppressive tumor microenvironments (TME) restrict the effectiveness of sonodynamic and nanocatalytic therapy (SDT/NCT). Herein, RuO<sub>2</sub> shell is utilized as the auxiliary sonosensitizers and nanozymes to sensitize Co<sub>3</sub>O<sub>4</sub> core for the construction of core-shell Co<sub>3</sub>O<sub>4</sub>@RuO<sub>2</sub> heterojunction sonozymes. Enhanced sonodynamic and multienzyme-mimic activities are observed in the heterojunction sonozymes, thanks to improved electron-hole separation kinetics. Co<sub>3</sub>O<sub>4</sub>@RuO<sub>2</sub>-triggered cascade amplification of antitumor immune response is realized by the heterojunction construction, GSH depletion, and relief of hypoxia co-augmented ROS yield, which significantly induced a robust ICD effect. Significant antitumor effects have been observed to eliminate primary tumors and stop the growth of distant tumors through Co<sub>3</sub>O<sub>4</sub>@RuO<sub>2</sub>-mediated SDT and NCT co-amplified immunotherapy. This study provides promising insights into the development of heterojunction sonozymes as a novel antitumor nanoplatform to induce durable and potent immune responses.
Authors
- Rui Ma (ORCID: https://orcid.org/0000-0002-9262-3453)
- Chaojun Zhang (ORCID: https://orcid.org/0000-0002-8195-9322)
- Bijiang Geng (ORCID: https://orcid.org/0000-0003-4819-2577)
- Guijun Zou
- Nan Wang (ORCID: https://orcid.org/0000-0003-4669-2738)
- Bing Ma (ORCID: https://orcid.org/0000-0003-1397-9556)
Institutions
- Shanghai University (CN)
- Chinese PLA General Hospital (CN)
- PLA Academy of Military Science (CN)
Publication Details
- Journal
- Small
- Published
- 2025-10-14
- DOI
- https://doi.org/10.1002/smll.202507712
- Citations
- 1
- Primary Topic
- Nanoplatforms for cancer theranostics
- Type
- article
- Field-Weighted Citation Impact
- 0.67